Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

<p>Abstract</p> <p>Background</p> <p>The prognosis of pT1a-pT1b breast cancer (BC) used to be considered very good, with a 10-y RFS of 90%. However, some retrospective studies reported a 10-y RFS of 81%–86% and suggested benefit from adjuvant systemic therapy.</p>...

Full description

Bibliographic Details
Main Authors: Gori Stefania, Clavarezza Matteo, Siena Salvatore, Foglietta Jennifer, Tarenzi Emiliana, Giordano Monica, Molino Annamaria, Graiff Claudio, Fusco Vittorio, Alabiso Oscar, Baldini Editta, Gamucci Teresa, Altavilla Giuseppe, Dondi Davide, Venturini Marco
Format: Article
Language:English
Published: BMC 2012-04-01
Series:BMC Cancer
Subjects:
pT1a and pT1b breast cancer
Adjuvant chemotherapy
Adjuvant hormonal therapy
Online Access:http://www.biomedcentral.com/1471-2407/12/158

Internet

http://www.biomedcentral.com/1471-2407/12/158

Similar Items